Norfluoxetine, Urine
Norfluoxetine is one of the Selective Serotonin Reuptake Inhibitors typically known as SSRIs, and belong to the class of drugs known as antidepressants. Norfluoxetine is the most important active metabolite of fluoxetine and exhibits similar pharmacologic effects as fluoxetine. The SSRIs have become the most widely used group of antidepressants in the U.S. The SSRIs typically do not elicit the anticholinergic side effects of the TCAs, are easier to tolerate, and are not as toxic and therefore safer for the patient. The SSRIs are well absorbed and reach peak serum concentrations within 2-12 hours. SSRIs are lipophilic and have large volumes of distribution.
The half-life of norfluoxetine is between 26-220 hours, and thus it takes a long time to achieve steady state concentrations in serum. Many of the therapeutic ranges for these drugs have not been established or there is non-consensus. The effects associated with fluoxetine abuse include hallucinations, tachycardia, seizures, nausea, vomiting, tremors, and coma when taken to excess.
- Therapeutic monitoring
- Drug abuse evaluation
- Toxicity assessment
- Patient compliance
Therapeutic levels (fluoxetine and norfluoxetine): 120 – 300 ng/mL
Toxic levels: variable
Fatality levels: variable
Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administration are preferred for pharmacokinetic analyses.
Cut-Off Ranges
Cut-off values can vary based on the particular method of analysis that is used for detection by a quantitative method, such as LC/MS or GC/MS. The testing laboratory cut-off range is listed on the patient report. Consult your physician for further information or click on one of the references that are listed below.
Fresh urine specimen collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Adulteration of the urine specimen can result in erroneous results.
Serum specimens that are collected in a non-gel red top tube are the preferred specimens of choice. Specimens should be spun and the serum separated and refrigerated.
Stability
- Ambient: 5 days
- Refrigeration: 7 days
- Frozen: 30 days
- Antidepressant DEA Drug Fact Sheet
- Levine B (ed). Principles of Forensic Toxicology, 4th Ed. Washington DC: AACC Press.,Washington DC. Chapter 14, Therapeutic Drugs II: Antidepressants. 403-420; 2013.
- Balant-Gorgia AE and Balant LP. Therapeutic drug monitoring of antidepressants. Clin Thera. 1992;14(4):612-4.
- Baselt RC (ed). Analytical procedures for therapeutic drug monitoring and emergency toxicology, 2nd ed. Littleton, MA: PSG Publishing Co.; 1987.
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 6th ed. Foster City, CA: Biomedical Publications; 2002.
- Fitzgerald R. Analytical toxicology of the benzodiazepines. AACC Therapeutic Drug Monitoring and Toxicology. 1995;16(7):169-79.
- Harman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds). Goodman and Gilman’s the pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill Co.;1996.
- Wians FH. Benzodiazepine update. AACC Therapeutic Drug Monitoring and Toxicology. 1989;11(4):7-20.
- Zherdev VP, Caccia S, Garattini S, Ekonomov AL. Species differences in phenazepam kinetics and metabolism. Euro J Drug Metab Pharm. 1982;7:191-6.